positive regulation of endothelial cell apoptotic process
about
Fas ligand (TNF superfamily, member 6)Chemokine (C-C motif) ligand 12CD40 ligandBone morphogenetic protein 4Integrin alpha 4CD40 ligandForkhead box O3Programmed cell death 4Phospholipase C gamma 1Aldo-keto reductase family 1 member C3Anoctamin 6Protein kinase C iotaCD248 moleculeEndothelial cell surface expressed chemotaxis and apoptosis regulatorCollagen type XVIII alpha 1 chainX-box binding protein 1Regulator of cell cycleCD160 moleculeCD40 moleculeAldo-keto reductase family 1, member C18G protein-coupled estrogen receptor 1CD40 antigenAnoctamin 6Advanced glycosylation end product-specific receptorCollagen, type XVIII, alpha 1Endothelial cell surface expressed chemotaxis and apoptosis regulatorProgrammed cell death 4CD248 antigen, endosialinPhospholipase C, gamma 1CD160 antigenForkhead box O3Protein kinase C, iotaRegulator of cell cycleThrombospondin-1X-box binding protein 1C-C motif chemokine ligand 2Programmed cell death 4G protein-coupled estrogen receptor 1Protein kinase C, iotaFas ligand
P682
Anoctamin 6 is an essential component of the outwardly rectifying chloride channelProtein kinase C iota mediates lipid-induced apoptosis of human coronary artery endothelial cellsA20 protects from CD40-CD40 ligand-mediated endothelial cell activation and apoptosisPlasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosisResponse gene to complement 32, a novel hypoxia-regulated angiogenic inhibitorIdentification of ARIA regulating endothelial apoptosis and angiogenesis by modulating proteasomal degradation of cIAP-1 and cIAP-2Thrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/caspase-3 axisMiR-30s Family Inhibit the Proliferation and Apoptosis in Human Coronary Artery Endothelial Cells Through Targeting the 3'UTR Region of ITGA4 and PLCG1.MicroRNA-495 regulates the proliferation and apoptosis of human umbilical vein endothelial cells by targeting chemokine CCL2Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells
P921
Q14866122-3972C219-4BF8-4FFC-BF57-5B14C420FD46Q14885647-C4D21043-7F75-4D59-A325-BD161FB3B6C1Q14901295-FCA6EF78-26C4-4BF1-8675-62D770DFC1A6Q14903410-26F782F2-C200-4989-B5A6-946A8CC8827FQ14912102-37ABC0AD-DCE4-4506-B6CE-AB68FA42FB00Q2071144-3B461757-BF2D-4880-9336-6F7CC6D7F034Q21101484-FBFAD684-5BD8-4D02-A3CA-6D637DAFB076Q21101882-30D2CE2B-6B7C-407A-8B0E-5ED4C2FDEDD8Q21104742-42534734-C3BF-40DA-BAA3-6D1D493357CBQ21105060-64B3FBB5-39D9-4969-9BC4-5A7E3C05ADF4Q21105169-B8BCC028-347B-4ABA-8B19-CBF5B5133A4AQ21109253-D5C851C2-7AD5-446F-AEB4-569A55A39BD7Q21114034-9B2DB239-3E40-46BA-97A0-026AA3B36D92Q21115835-8C983A1F-8303-40A8-BE6E-9FE53F7DEC67Q21115835-CF33FE29-1D03-4ED4-93BC-E52F2CE3DDC2Q21116171-F10A6DAA-9181-4489-B510-AA0559F960C8Q21116794-1AC68246-021E-4F82-A01D-2848D9C12941Q21123834-A2951C66-E2FC-47F0-85FC-0AA50B919E3AQ21130546-B9731544-56FB-473C-AEE4-33E7BDDE189BQ21135811-E2D26DE9-518E-4633-A89F-8F7AE0964D19Q21421968-DE7ED361-1FE8-472C-8743-DCB4399505E8Q21494462-AAC6D85B-FD09-461A-A08F-D9B0F81FF208Q21494906-9CA9434A-B098-4D59-8C70-A34FBDEA7F96Q21496064-5B61E2C2-7724-4BAF-A602-9313092361FDQ21496784-6F521794-A470-4A6B-9D0D-1952A93C00EBQ21497353-8F98C72A-AB9F-456F-9F92-C66750683757Q21497542-55EE685C-C8D1-4C71-936E-E7B31D5BAE99Q21497542-BEC791E5-A2BD-4925-8E1F-80FFE961DC44Q21498623-25CBDA95-9505-4E85-A772-E9771F9E2024Q21979865-FF82EFC8-55E1-43DE-B7A8-10EEA2107F1FQ21981079-178DAB6D-885A-409C-AD69-3F05D18DBBAEQ21981237-5349AEFD-B047-4472-A7C9-6B332CF6CD8FQ21981237-71EADD7C-A4CA-4BE5-A0CC-39C1C973F2ACQ21981986-9C38A035-ED0E-4E8A-9D1F-C676FE2F6C07Q21984346-DFDA1FDF-2FAC-4C79-B5DB-CB5FB818D80EQ21987966-8923C7D5-8533-4BB8-B96C-4160CDC64751Q21992233-E51C144E-8CCC-415F-A73D-B421F2880380Q21992827-5C8FCDFC-2427-47E2-B039-2CBC2652EBFCQ2587862-2133D0CC-3C09-4FEF-9D49-04394FAEC2E0Q28557313-9F84E7D8-EF3D-487D-9987-2736AD25E934
P682
Q24293563-A9943859-4AA4-4514-9430-0B8C6D296415Q24310371-FCF796C2-2142-40B2-AF15-36CEECF88949Q24311688-C79D2D07-B329-4B69-9A32-677D54E5BDAEQ24319106-FEC5D811-E86F-45F1-AFB2-92747C6D62D6Q24320745-22467613-0778-4034-B518-CA4E08416D9DQ24322043-CA54F099-5E01-4228-8703-A55FD82115F4Q24336644-131944FF-1812-4289-A13A-B5CE480A9DC9Q28119196-69959C71-9BAE-473B-8159-54829CF36AF9Q39554114-EC0EF53F-6755-4A5B-A422-804F1165B12DQ51118725-E96580CB-1B39-4B5E-BAED-8D5A9B4DD8F1Q60273498-7C8C24EC-02D1-49D2-9314-200FEAB0D176
P921
positive regulation of endothelial cell apoptotic process
description
Any process that activates or ...... helial cell apoptotic process.
@en
biologisch proces
@nl
name
positive regulation of endothelial cell apoptotic process
@en
type
label
positive regulation of endothelial cell apoptotic process
@en
altLabel
GO:2000353
@en
positive regulation of apoptosis of endothelial cells
@en
positive regulation of endothelial cell programmed cell death by apoptosis
@en
positive regulation of killing of endothelial cells
@en
positive regulation of programmed cell death of endothelial cells by apoptosis
@en
positive regulation of programmed cell death, endothelial cells
@en
prefLabel
positive regulation of endothelial cell apoptotic process
@en
P279
P2888
P686
GO:2000353